UOC
IOVA icon

UBS O'Connor’s Iovance Biotherapeutics IOVA Stock Holding History

UBS O'Connor’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-90,000
Closed -$2.25K – 428
2024
Q4 		$2.25K Buy
+90,000
New +$834K ﹤0.01% 414
2024
Q2 		– Sell
-40,000
Closed -$20K – 617
2024
Q1 		$20K Sell
40,000
-290,000
-88% -$3.38M ﹤0.01% 461
2023
Q4 		$900K Buy
330,000
+100,000
+43% +$523K 0.03% 281
2023
Q3 		$190K Buy
+230,000
New +$1.5M ﹤0.01% 450
2023
Q2 		– Sell
-100,000
Closed -$52.5K – 635
2023
Q1 		$52.5K Buy
+100,000
New +$690K ﹤0.01% 546

Other funds holding IOVA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MFM
MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $2.28B AUM 7.31% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return